title: Development of sympathetic cardiovascular control in embryonic, hatchling, and yearling female American alligator (Alligator mississippiensis).
abstract: We used arterial tyramine injections to study development of sympathetic actions on in vivo heart rate and blood pressure in embryonic, hatching and yearling female American alligators. Tyramine is a pharmacological tool for understanding comparative and developmental sympathetic regulation of cardiovascular function, and this indirect sympathomimetic agent causes endogenous neuronal catecholamine release, increasing blood pressure and heart rate. Arterial tyramine injection in hatchling and yearling alligators caused the typical vertebrate response - rise in heart rate and blood pressure. However, in embryonic alligators, tyramine caused a substantial and immediate bradycardia at both 70% and 90% of embryonic development. This embryonic bradycardia was accompanied by hypotension, followed by a sustained hypertension similar to the hatchling and juvenile responses. Pretreatment with atropine injection (cholinergic receptor blocker) eliminated the embryonic hypotensive bradycardia, and phentolamine pretreatment (α-adrenergic receptor blocker) eliminated the embryonic hypotensive and hypertensive responses but not the bradycardia. In addition, hexamethonium pretreatment (nicotinic receptor blocker) significantly blunted embryos' bradycardic tyramine response. However, pretreatment with 6-hydroxydopamine, a neurotoxin that destroys catecholaminergic terminals, did not eliminate the embryonic bradycardia. Tyramine likely stimulated a unique embryonic response - neurotransmitter release from preganglionic nerve terminals (blocked with hexamethonium) and an acetylcholine mediated bradycardia with a secondary norepinephrine-dependent sustained hypertension. In addition, tyramine appears to stimulate sympathetic nerve terminals directly, which contributed to the overall hypertension in the embryonic, hatchling and yearling animals. Data demonstrated that humoral catecholamine control of cardiovascular function was dominant over the immature parasympathetic nervous system in developing alligator embryos, and suggested that sympathetic and parasympathetic nerve terminals were present and developing in ovo but were not tonically active.
authors.affiliation: Department of Biological Sciences, University of North Texas, Denton, TX 76203, USA. johneme23@gmail.com
authors.forename: John
authors.initials: J
authors.lastname: Eme
authors.forename: Ruth M
authors.initials: RM
authors.lastname: Elsey
authors.forename: Dane A
authors.initials: DA
authors.lastname: Crossley
mesh_terms: D000489:Alligators and Crocodiles / Q000196:embryology / Q000254:growth & development / Q000502:physiology*; D000704:Analysis of Variance; D000818:Animals; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002319:Cardiovascular System / Q000196:embryology / Q000254:growth & development / Q000294:innervation*; D004625:Embryo, Nonmammalian / Q000187:drug effects / Q000196:embryology / Q000503:physiopathology; D005260:Female; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology*; D007269:Injections, Intra-Arterial; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology; D010646:Phentolamine / Q000008:administration & dosage / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000502:physiology*; D013566:Sympathomimetics / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors; D014439:Tyramine / Q000008:administration & dosage / Q000494:pharmacology; D014481:United States
chemical_list: D010276:Parasympatholytics; D013566:Sympathomimetics; D001285:Atropine; D014439:Tyramine; D010646:Phentolamine